Kuramochi, Takahiro published the artcileDiscovery of an N-(2-aminopyridin-4-ylmethyl)nicotinamide derivative: a potent and orally bioavailable NCX inhibitor, HPLC of Formula: 639091-75-1, the main research area is aminopyridinyl nicotinamide preparation sodium calcium exchanger SAR.
Ca2+ overload in myocardial cells is responsible for arrhythmia. Sodium-calcium exchanger (NCX) inhibitors are more effective than sodium-hydrogen exchanger (NHE) inhibitors with regard to modulation of Ca2+ overload, because NCX inhibitors can directly inhibit the influx of Ca2+ into cells. NCX is an attractive target for the treatment of heart failure and ischemia-reperfusion. We have designed and synthesized a series of N-(2-aminopyridin-4-ylmethyl)nicotinamide derivatives We have discovered a novel NCX inhibitor (I) with an IC50 value of 0.12 μM against reverse NCX. The inhibitory activities of our NCX inhibitors against cytochrome P 450 were also evaluated. The effects on heart failure and the pharmacokinetic profile of I are discussed.
Bioorganic & Medicinal Chemistry published new progress about Heart failure. 639091-75-1 belongs to class esters-buliding-blocks, name is Methyl 2-((tert-butoxycarbonyl)amino)isonicotinate, and the molecular formula is C12H16N2O4, HPLC of Formula: 639091-75-1.
Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics